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Abstract
Background: There are three distinct subtypes of Trichorhinophalangeal syndrome (TRPS); TRPS type I, TRPS type II
and TRPS type III. Features common to all three subtypes include sparse, slowly growing scalp hair, laterally sparse
eyebrows, a bulbous tip of the nose (pear-shaped), and protruding ears. Langer–Giedion syndrome (LGS) or TRPS
type II is a contiguous gene syndrome on 8q24.1, involving loss of functional copies of the TRPS1 and EXT1 genes.
We report a male patient that was referred to the Department of Medical Genetics due to hypotonia and
dysmorphic facial features.
Results: Cytogenetic and array- Comparative Genomic Hybridization (aCGH) analysis revealed that the patient was a
carrier of an interstitial deletion at 8q23.1-q24.12 of 12,5 Mb. Parental karyotype indicated that the father carried an
apparently balanced insertion: 46, ΧΥ, der(10)ins(10;8)(q22;q23q24).
Conclusions: This is the first report of an apparently balanced insertion including chromosomes 8 and 10 contributing
to the etiology of LGS/ TRPS type II. Τimely diagnosis of parental balanced chromosomal rearrangements can reduce
the risk of subsequent miscarriages as well as abnormal offspring.
Background
Langer–Giedion syndrome (LGS) or Trichorhinopha-
langeal syndrome (TRPS) type II is a contiguous gene
syndrome on 8q24.1, involving loss of functional copies
of the TRPS1 and EXT1 genes, that was first described
by Andreas Giedion, a Swiss pediatric radiologist. In
1966, he reported the association of slowly growing
hair, a long pear-shaped nose with a bulbous tip, and
finger deformities. In 1969, Giedion A. and Leonard O.
Langer Jr. independently described a patient with these
features as well as multiple exostoses. In 1974, the
name LGS or TRP II was introduced subsequently by
Hall et al. [1]. The diagnosis of TRPS type I, II and III
is based on clinical and radiographic features as well as
on genetic analysis that is helpful especially in the case
of non-classical clinical presentation.
TRPS type I caused by mutations in the TRPS1 gene
located on chromosome 8q24.1, characterized by
distinctive skeletal abnormalities and craniofacial
dysmorphism.
TRPS type II represents a contiguous gene syndrome
involving loss of functional copies of the TRPS1 and
EXT1 genes and is characterized by multiple exostoses
and intellectual disability (ID) in addition to the
classical triad of symptoms.
TRPS type III is caused by mutations in TRPS1 gene
and includes severe short stature and brachydactyly in
the absence of exostoses [2].
It is postulated that nonsense mutations are usually re-
sponsible for the TRPS type I phenotype, while missense
mutations cause the TRPS type III phenotype [3]. The
mode of inheritance in TRPS I and III is autosomal
dominant. In contrast, TRPS II (LGS) is usually sporadic
and caused by the deletion of contiguous genes in the
long arm of chromosome 8 (8q24.11-13), involving loss
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of functional copies of the TRPS1 and the EXT1 genes
[4, 5].
In TRPS I and III, the eyebrows may be thickened
medially and thin or even absent laterally. In TRPS II,
the eyebrows could be normal. Sparse eyelashes and sec-
ondary sexual hairs may be evident. A long pear-shaped
nose with bulbous tip and a long philtrum are character-
istic. Deformities of the fingers and toes can result from
cone-shaped epiphyses and irregular premature fusion,
which could be mistaken as juvenile rheumatoid arthritis
[1]. The middle phalanges are most commonly involved.
Sometimes there is an abnormal patella with recurrent
dislocation. Perthes-like change of the hip is common
and can lead to severe secondary osteoarthritis in the
adult [1, 6]. In TRPS II, patients have additional features
of multiple exostoses from early childhood, microceph-
aly, skin and joint laxity. Mental impairment is common.
Features common to all three disorders include sparse,
slowly growing scalp hair, laterally sparse eyebrows, a
bulbous tip of the nose (pear-shaped), and protruding
ears. Further typical characteristics comprise a long flat
philtrum and a thin upper vermillion border. Distinct
radiographic findings are often not detectable before
2 years of age.
Clinical Phenotype/Genotype correlation in LGS/
TRPS II
The LGS/TRPII comprises the clinical features of two
separate autosomal dominant diseases : the multiple her-
editary exostoses (MHE) type I caused by mutation in
the gene encoding exostosin-1 (EXT1), and the TRPS
type I caused by haploinsufficiency of the TRPS1 gene.
The MHE is a genetically heterogeneous disorder which
can be caused by mutations in the EXT1, EXT2 or EXT3
gene [7].
The LGS/TRPSII shows some clinical variability
depending on the loss of additional genes in the deleted
region [8, 9]. Mild to moderate intellectual disability,
congenital nephrotic syndrome [10], hydrometrocolpos
[11], conductive hearing loss [12], growth hormone defi-
ciency [13], persistent cloaca and prune belly sequence
[14], and a submucous cleft palate [15] have all been de-
scribed as additional features of LGS/TRPSII depending
on the deletion size.
Although deletions of the 8q region are rare and con-
siderably variable, the shortest region of deletion overlap
(SRO) has been defined at 8q24.1, spanning 2 Mb, in-
cluding TRPS1, EIF3S3, RAD21, OPG, CXIV and EXT1
genes [16].
Heterozygous mutations of the RAD21 gene at
8q24.11 were recently found to cause Cornelia de
Lange syndrome- 4 (CdLs-4), which is characterized by
growth deficiency, mental retardation, microcephaly,
bushy eyebrows and synophrys, depressed nasal bridge,
micrognathia, micromelia, hearing loss, anteverted nares,
prominent symphysis and spurs in the anterior angle of
mandible, gastrointestinal problems (such us gastroesoph-
ageal reflux, duplication of the gut, malrotation of colon
with volvulus and pyloric stenosis). There are occasional
seizures, congenital heart defects and inguinal hernias
[17–19].
TRPS type I, LGS/TRPSII and CdLs-4 share many fa-
cial features; some patients affected by LGS/TRPSII with
deletions involving RAD21 and not TRPS1, present typ-
ical facial dysmorphisms. LGS/TRPSII patients’ facial
hallmarks might be partially influenced by RAD21.
Moreover, the phenotypic consequences of RAD21 dis-
ruption might be underestimated in these patients [20].
Parental apparently-balanced chromosomal
insertion in the etiology of LGS/TRPSII
Structural aberrations in human chromosomes can be ini-
tiated by chromosomal breakage and incomplete repair. If
the chromosomal aberration is balanced, copy number for
all interrogated genomic regions is disomic. However,
most chromosomal aberrations are unbalanced, resulting
in duplication or deletion of genetic material at the
chromosomal breakpoints. The frequency of insertional
translocation is estimated by karyotyping on severely men-
tally retarded patients (4:40,000) [21]. Microscopically vis-
ible insertional translocations occur with a frequency of
1:80.000 in newborns [22]. However, the frequency is also
estimated as high as 1:500 using array-based comparative
genome hybridization (aCGH) as a detection method in
conjunction with FISH [23].
The frequency of balanced chromosomal insertions is
much lower than reciprocal translocations because it
requires three chromosomal breaks. Parental balanced
insertions increase the possibility of copy number im-
balances in the offspring resulting in congenital anom-
alies of multiple organ systems and psychomotor
retardation. aCGH analysis revealed that approximately
2.1 % of parents with offspring having developmental
anomalies, harbor balanced insertions [24]. In this re-
gard, genomic analysis of the parental DNA of a patient
may help us to exclude the possibility of parental bal-
anced translocations as predisposing genetic risk.
We report an LGS/TRPSII patient with an 8q23.1-
q24.12 microdeletion, caused by a parental apparently
balanced insertion ( 46,XY, der(10)ins(10;8)(q22;q23q24).
Case presentation
Clinical report
Our male patient was the first child of healthy unrelated
parents of normal intelligence. He was born by caesarian
section at 40 weeks of gestation after an uneventful preg-
nancy. His birth weight was 3090 gr (25th centile), length
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49 cm (25th centile) and head circumference 33 cm (25th
centile). Previously the mother had suffered a miscarriage.
He was referred to our Department of Clinical Genetics
at 2 months due to hypotonia and dysmorphic facial fea-
tures. On clinical examination the patient presented with
brachycephaly, low anterior hairline, a depressed and broad
nasal bridge, a bulbous tip of the nose, a long and flat phil-
trum, a thin upper lip vermilion, a high palate, retro-
micrognathia and downslanting palpebral fissures (Fig. 1a).
He had large laterally protruding ears (Fig. 1b), bilateral
pre-axial polydactyly (Fig. 1c), long fingers and cryptorchid-
ism. Heart and abdominal ultrasound revealed no patho-
logical abnormalities. The brain MRI showed dysplastic
corpus callosum. The opthalmological examination was




Cytogenetic analysis was performed on GTG-banded
metaphases at a resolution of 500 bands approximately.
The samples were subjected to blood lymphocyte culture
according to the standard cytogenetic protocol. The de-
scription of karyotypes were made in accordance with
the ISCN 2013 (International System of Human Cyto-
genetic Nomenclature).
Array-CGH analysis (aCGH)
After informed consent from the parents, genomic DNA
from the patient and the father was obtained from 3 ml
of peripheral blood using the BioRobot® M48 System
(Qiagen, Hilden, Germany) and the commercially avail-
able kit MagAttract® DNA Blood Midi M48 Kit (Qiagen).
The quality and quantity of the DNA samples was deter-
mined using a NanoDrop ND-1000 UV–VIS spectro-
photometer. Agilent Human Genome 4X180K CGH +
SNP arrays were used in this study (Agilent Technolo-
gies, Santa Clara, CA, www.agilent.com). Labelling and
hybridization was carried out according to the manufac-
turer’s recommendations. Data were processed using
Feature Extraction and analysed using Cytogenomics
vs.3.0 software (Agilent Technologies, CA) with the
following settings: Algorithm: ADM-1, Threshold: 6.7,
with a minimum of 4 probes for a region to be included.
Centralization and fuzzy zero corrections were applied




G-banded chromosomal analysis from the peripheral
blood of the patient displayed a male karyotype with an
apparent deletion on one chromosome 8q (46,XY,
del(8)(q23→ q24)pat) (Fig. 2). The maternal karyotype
was normal (46,XX), however the paternal karyotype re-
vealed an apparently balanced insertion: 46, ΧΥ, der(10)
ins(10;8)(q22;q23q24).
Array-CGH analysis (aCGH)
Whole genome a-CGH revealed an interstitial deletion at
8q23.1-q24.12 of 12,5 Mb (HGVS:NC_000008.10:g.(?_108,
776,506)_(121,312,414_?)del; GRCh37/hg19). The deletion
included the following genes: RSPO2, EIF3E, TTC35,
TMEM74, TRHR, NUDCD1, ENY2, PKHD1L1, EBAG9,
SYBU, KCNV1, CSMD3, MIR2053, TRPS1, EIF3H, UTP23,
RAD21, NCRNA00255, MIR3610, C8orf85, SLC30A8,
MED30, EXT1, SAMD12, TNFRSF11B, COLEC10, MAL2,
NOV, ENPP2, TAF2, DSCC1, DEPTOR, COL14A1 (Fig. 3).
The paternal result included only copy number polymor-
phisms (CNPs), therefore the father carried a balanced
insertion.
Discussion and conclusions
Parental balanced chromosomal rearrangement is an im-
portant cause of copy number alteration in the offspring.
A recent study revealed that approximately 2.1 % of du-
plications and deletions associated with developmental
delay originated from parental balanced chromosomal
aberrations [24]. Repeat sequences, such as low copy re-
peats (LCR) around the region of breakage are thought
to mediate misalignment between the repeat regions
during meiosis, leading to unequal recombination events
[25]. However, the incidence of cytogenetically-visible in-
sertions is low [21], and the potential parental carrier
cba
Fig. 1 Dysmorphic features in a LGS patient, that was referred to our Department of Medical Genetics. a A bulbous tip of the nose, a long and
flat philtrum and a thin upper lip vermilion, b large laterally protruding ears and a depressed and broad nasal bridge and c pre-axial polydactyly
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status cannot be easily detected. Parental FISH analysis
as well as aCGH should be considered as part of the
clinical baseline testing, in all families, where a de novo
interstitial aberration is suspected. By identifying paren-
tal interstitial aberrations, both prenatal and preimplan-
tation genetic counseling should be offered to reduce
the risk of subsequent miscarriages as well as chromo-
somally abnormal offspring [26].
We were able to demonstrate that using a combination
of karyotyping and aCGH, an insertion involving chro-
mosomes 8 and 10 in a phenotypically normal father
caused LGS/TRPSII in the proband. The 8q23.1-q24.12
2
Fig. 2 Cytogenetic analysis. G-banded chromosomal analysis from the peripheral blood of the LGS patient displayed a male karyotype with an
apparent deletion on one chromosome 8q (46,XY, del(8)(q23→ q24)pat)
3
Fig. 3 Molecular cytogenetic analysis. Whole genome array-CGH revealed an interstitial deletion at 8q23.1-q24.12 of 12,5 Mb (HGVS:NC_000008.10
:g.(?_108,776,506)_(121,312,414_?)del; GRCh37/hg19) in our LGS patient
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deletion of 12.5 Mb, contains 33 genes of which TRPS1,
EXT1, and RAD21 could be considered responsible for
the core phenotypic features of the proband. Although
deletions of the 8q region are rare and considerably vari-
able, the shortest region of deletion overlap (SRO) has
been identified as spanning 2 Mb, including TRPS1,
EIF3S3, RAD21, OPG, CXIV, EXT1 genes [16]. To our
knowledge, this is the first report of an apparently bal-
anced insertion including chromosomes 8 and 10 con-
tributing to the etiology of LGS/TRPSII.
Recently, defects in RAD21 have been associated with
CdLs-4. Although recognizable, the face and hair of pa-
tients with LGS/TRPSII are variable and typically related
to TRPS1 disruption [27]. In our patient, aCGH analysis
revealed the deletion of both TRPS1 and RAD21 genes
which is in accordance with the dysmorphic facial fea-
tures. TRPS type I, LGS/TRPSII and CdLs-4 share many
facial features. Autosomal dominant missense mutations
result in more severe functional, structural and cognitive
clinical findings compared to loss-of-function mutations
or deletions. In RAD21 haploinsufficiency or heterozy-
gous loss-of-function mutation may cause the LGS/
TRPSII affected individuals to have mild CDLS stigmata
too [19].
In LGS/TRPSII patients, the more distal the proximal
breakpoint is located from the TRPS1 gene, the fewer
typical features of LGS/TRPSII are observed [28]. In that
case, the TRPS1 gene expression may be altered if the
proximal breakpoint occurs near the gene where a po-
tential regulatory sequence, such as gene enhancer or re-
pressor is located. Thus, the location of the proximal
breakpoint causes a functional disturbance of the TRPS1
gene. The size of the critical region outside the TRPS1
gene which contains the regulatory sequence is yet to be
determined. Another possibility is that the newly formed
chromosomal imbalance may cause a silencing effect on
the TRPS1 gene by placing it in close proximity to an-
other gene [29].
Nearly 70 % of LGS/TRPSII affected individuals may
exhibit mild to severe cognitive disability [30]. Although
delay in the LGS/TRPSII syndrome has been attributed
to the deletion of genes outside the TRPS1-EXT1 inter-
val, specific genes have yet to be identified. The size of
the 8q deletion is directly correlated with intellectual
disability (ID)[13].
In our patient, the 8q deletion spans 12,5 Mb and the
genes potentially involved were: CSMD3, MED30,
SAMD12, EIF3H, RAD21 and TAF 2. In particular,
CSMD3 has previously been suggested as a good candi-
date for pathogenesis of developmental delay in LGS/
TRPSII patients. RAD21 mutations or deletions have
been observed in CdLs patients with very mild intellec-
tual disability (ID) [19]. Mutations in the TAF2 gene are
also related with ID [31, 32].
Although more than 100 patients with LGS/TRPSII
have been reported in the literature, there is little long-
term follow-up and knowledge about the course and po-
tential further health complications during adulthood
and advanced age. In our patient, clinical reevaluation at
six months revealed feeding difficulties and delayed psy-
chomotor development.
The number of distinct syndromes due to specific
chromosome imbalance is rapidly increasing, especially
since a-CGH allows detection of submicroscopic aberra-
tions of virtually any segment. Confirmation of LGS/
TRPSII using the appropriate genetic analysis is neces-
sary especially in cases of non-classical clinical presenta-
tion [33].
Skeletal and orthopedic problems continue to be an
important issue. Severe scoliosis and orthopedic prob-
lems due to joint laxity, Perthes disease, asymmetry of
legs and joint immobility due to adjacent exostoses are
among the most frequent problems. On the other hand,
eye, ear, and cardiac problems are rarely of major rele-
vance [33].
Τimely diagnosis of parental balanced chromosomal re-
arrangements using the appropriate techniques is import-
ant and can reduce the risk of subsequent miscarriages as
well as abnormal offspring; in our case neither parental
karyotype nor amniocentesis were performed for prenatal
testing. The monosomy 8q23-q24 observed in the affected
child resulted from segregation during paternal meiosis,
due to the apparently balanced chromosomal insertion in
the father 46, ΧΥ, der(10)ins(10;8)(q22;q23q24).
With better knowledge on the long-term course,
complications and molecular defects that cause LGS/
TRPSII, genetic counseling is necessary. Clinical geneti-
cists should provide information for the families, to ad-
vise them about the course of the disease and how to
overcome problems [33].
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